Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BFLY Butterfly Network	$2.18 +1.9%	$2.35	$0.82 ▼ $4.98	$539.09M	2.59	2.94 million shs	3.92 million shs
BVS Bioventus	$6.53 +0.3%	$7.79	$5.28 ▼ $14.38	$536.40M	0.95	455,886 shs	587,066 shs
KIDS OrthoPediatrics	$20.83 -1.5%	$22.54	$20.25 ▼ $35.99	$505.90M	1.09	196,497 shs	72,124 shs
PROF Profound Medical	$5.13	$5.13	$3.90 ▼ $11.42	$154.17M	0.44	63,319 shs	43,628 shs

The Best Nuclear Energy Stocks to Buy

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BFLY Butterfly Network	+1.49%	-7.82%	-8.40%	-49.01%	+109.62%
BVS Bioventus	+0.31%	-3.83%	-13.97%	-34.77%	+3.65%
KIDS OrthoPediatrics	-1.51%	-9.71%	+0.29%	-12.33%	-37.16%
PROF Profound Medical	0.00%	+8.92%	+9.38%	-31.42%	-35.39%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BFLY Butterfly Network	2.638 of 5 stars	3.5	3.0	0.0	2.2	2.5	0.6
BVS Bioventus	3.0714 of 5 stars	3.3	0.0	0.0	2.4	4.2	1.3
KIDS OrthoPediatrics	4.6016 of 5 stars	4.4	1.0	3.9	3.8	4.2	0.6
PROF Profound Medical	2.5423 of 5 stars	3.5	2.0	0.0	2.8	2.5	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BFLY Butterfly Network	3.00	Buy	$4.00	83.49% Upside
BVS Bioventus	2.67	Moderate Buy	$14.33	119.50% Upside
KIDS OrthoPediatrics	2.83	Moderate Buy	$35.83	72.03% Upside
PROF Profound Medical	3.00	Buy	$11.50	124.17% Upside

Current Analyst Ratings Breakdown

Latest PROF, BFLY, BVS, and KIDS Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
5/9/2025	PROF Profound Medical	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Strong-Buy ➝ Moderate Buy
5/8/2025	KIDS OrthoPediatrics	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$40.00 ➝ $30.00
5/8/2025	KIDS OrthoPediatrics	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$42.00 ➝ $42.00
5/7/2025	BVS Bioventus	Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Buy ➝ Buy	$15.00
5/5/2025	BFLY Butterfly Network	Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$5.00 ➝ $4.00
4/23/2025	PROF Profound Medical	Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$17.00 ➝ $11.00
4/11/2025	KIDS OrthoPediatrics	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Hold ➝ Hold	$26.00 ➝ $24.00
4/9/2025	KIDS OrthoPediatrics	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$42.00 ➝ $42.00
4/7/2025	KIDS OrthoPediatrics	Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$37.00
3/17/2025	BFLY Butterfly Network	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Outperform
3/17/2025	BVS Bioventus	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$15.00 ➝ $15.00

(Data available from 5/24/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BFLY Butterfly Network	$85.63M	6.30	N/A	N/A	$1.06 per share	2.06
BVS Bioventus	$567.70M	0.94	$0.52 per share	12.58	$2.80 per share	2.33
KIDS OrthoPediatrics	$212.45M	2.38	N/A	N/A	$16.14 per share	1.29
PROF Profound Medical	$11.86M	13.00	N/A	N/A	$1.28 per share	4.01

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BFLY Butterfly Network	-$133.70M	-$0.29	N/A	N/A	N/A	-129.25%	-42.68%	-30.31%	8/7/2025 (Estimated)
BVS Bioventus	-$156.23M	-$0.48	N/A	14.20	N/A	-7.11%	15.61%	4.01%	N/A
KIDS OrthoPediatrics	-$20.97M	-$1.75	N/A	N/A	N/A	-15.00%	-5.78%	-4.80%	8/4/2025 (Estimated)
PROF Profound Medical	-$28.57M	-$1.22	N/A	N/A	N/A	-349.41%	-85.22%	-64.87%	N/A

Latest PROF, BFLY, BVS, and KIDS Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/8/2025	Q1 2025	PROF Profound Medical	-$0.29	-$0.36	-$0.07	-$0.36	$4.78 million	$2.62 million
5/7/2025	Q1 2025	KIDS OrthoPediatrics	-$0.26	-$0.39	-$0.13	-$0.46	$51.68 million	$52.41 million
5/2/2025	Q1 2025	BFLY Butterfly Network	-$0.09	-$0.06	+$0.03	-$0.06	$21.16 million	$21.23 million
3/6/2025	Q4 2024	PROF Profound Medical	-$0.31	-$0.20	+$0.11	-$0.20	$5.92 million	$4.18 million
3/4/2025	Q4 2024	KIDS OrthoPediatrics	-$0.33	-$0.29	+$0.04	-$0.69	$51.16 million	$52.67 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BFLY Butterfly Network	N/A	N/A	N/A	N/A	N/A
BVS Bioventus	N/A	N/A	N/A	N/A	N/A
KIDS OrthoPediatrics	N/A	N/A	N/A	N/A	N/A
PROF Profound Medical	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BFLY Butterfly Network	N/A	4.66	2.95
BVS Bioventus	1.85	1.41	0.99
KIDS OrthoPediatrics	0.19	7.17	3.68
PROF Profound Medical	0.11	6.12	5.16

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BFLY Butterfly Network	37.85%
BVS Bioventus	62.94%
KIDS OrthoPediatrics	69.05%
PROF Profound Medical	47.86%

Insider Ownership

Company	Insider Ownership
BFLY Butterfly Network	25.18%
BVS Bioventus	32.90%
KIDS OrthoPediatrics	32.70%
PROF Profound Medical	1.52%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BFLY Butterfly Network	460	247.29 million	154.94 million	Optionable
BVS Bioventus	1,200	82.14 million	54.46 million	Not Optionable
KIDS OrthoPediatrics	200	24.29 million	16.52 million	Optionable
PROF Profound Medical	150	30.05 million	29.58 million	Optionable

PROF, BFLY, BVS, and KIDS Headlines

Recent News About These Companies

1 Magnificent Healthcare Stock Down 80% to Buy and Hold Forever

May 22 at 11:19 AM | fool.ca

Profound Medical Corp. (NASDAQ:PROF) CEO Purchases $43,312.99 in Stock

May 21 at 7:11 AM | insidertrades.com

Stonepine Capital Management LLC Acquires Shares of 200,000 Profound Medical Corp. (NASDAQ:PROF)

May 20, 2025 | marketbeat.com

Financial Review: Meihua International Medical Technologies (NASDAQ:MHUA) and Profound Medical (NASDAQ:PROF)

May 20, 2025 | americanbankingnews.com

Why Profound Medical Corp.’s (PROF) Stock Is Up 5.07%

May 16, 2025 | aaii.com

Profound Medical Annual General and Special Meeting of Shareholders Voting Results

May 14, 2025 | globenewswire.com

Profound Medical targets 70%-75% growth in 2025 with new TULSA AI module launch

May 9, 2025 | msn.com

Profound Medical Corporation (PROF) Q1 2025 Earnings Conference Call Transcript

May 9, 2025 | seekingalpha.com

Alyeska Investment Group L.P. Buys New Stake in Profound Medical Corp. (NASDAQ:PROF)

May 9, 2025 | marketbeat.com

Profound Medical Announces First Quarter 2025 Financial Results

May 9, 2025 | manilatimes.net

Profound Medical (PROF) Reports Q1 Loss, Misses Revenue Estimates

May 8, 2025 | zacks.com

Profound Medical Reports Strong Q1 2025 Growth and Highlights TULSA-PRO Advancements

May 8, 2025 | tipranks.com

1 Magnificent Canadian Stock Down 52% to Buy and Hold Forever

May 7, 2025 | msn.com

Profound Medical Corp. (NASDAQ:PROF) Shares Bought by Bleichroeder LP

May 7, 2025 | marketbeat.com

Strength Seen in Profound Medical (PROF): Can Its 8.3% Jump Turn into More Strength?

May 5, 2025 | zacks.com

Anson Funds Management LP Acquires Shares of 110,000 Profound Medical Corp. (NASDAQ:PROF)

May 5, 2025 | marketbeat.com

50,000 Shares in Profound Medical Corp. (NASDAQ:PROF) Acquired by AYAL Capital Advisors Ltd

May 5, 2025 | marketbeat.com

Profound Medical (PROF) to Release Quarterly Earnings on Thursday

May 3, 2025 | marketbeat.com

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Profound Medical Corp. - PROF

May 1, 2025 | accessnewswire.com

Profound Medical: In Serious Trouble Despite Projected Growth

April 30, 2025 | seekingalpha.com

Profound Medical to Present at 2025 Healthcare Investor Conference

April 30, 2025 | tipranks.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

Why D-Wave's Project With Davidson Is a Game-Changer For Quantum
By Nathan Reiff | April 30, 2025
View Why D-Wave's Project With Davidson Is a Game-Changer For Quantum
Tempus AI Stock: Time to Double Down or Cut and Run?
By Thomas Hughes | May 8, 2025
View Tempus AI Stock: Time to Double Down or Cut and Run?
Intel Refocuses: NEX Sale and Foundry Pivot Signal New Era
By Jeffrey Neal Johnson | May 21, 2025
View Intel Refocuses: NEX Sale and Foundry Pivot Signal New Era
Microsoft and OpenAI Just Hit Reset—Here’s Why MSFT Stock Wins
By Chris Markoch | May 15, 2025
View Microsoft and OpenAI Just Hit Reset—Here’s Why MSFT Stock Wins
These 4 Top Investors Bought Over 6 Million Broadcom Shares in Q1
By Leo Miller | May 22, 2025
View These 4 Top Investors Bought Over 6 Million Broadcom Shares in Q1

PROF, BFLY, BVS, and KIDS Company Descriptions

Butterfly Network NYSE:BFLY

$2.18 +0.04 (+1.87%)

Closing price 05/23/2025 03:59 PM Eastern

Extended Trading

$2.18 0.00 (0.00%)

As of 05/23/2025 07:37 PM Eastern

Butterfly Network, Inc. develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. It offers Butterfly iQ, a handheld and single-probe whole body ultrasound system; Butterfly iQ+ and iQ3 ultrasound devices that can perform whole-body imaging in a single handheld probe integrated with the clinical workflow, and accessible on a user's smartphone, tablet, and almost any hospital computer system; and Butterfly iQ+ Vet, a handheld ultrasound system designed for veterinarians. The company also provides Butterfly system, which includes probes, and related accessories and software subscriptions to healthcare systems, physicians, and healthcare providers through a direct sales force, distributors, and eCommerce channel. In addition, it offers cloud-based software solutions to healthcare systems, teleguidance, in-app educational tutorials, and formal education programs through its Butterfly Academy software, as well as professional services for large scale deployments; and ScanLab, an education-only app provides written walkthroughs and reference imagery to guide real-time educational scanning, enhancing the learning process. Butterfly Network, Inc. was founded in 2011 and is headquartered in Burlington, Massachusetts.

Bioventus NYSE:BVS

$6.53 +0.02 (+0.31%)

Closing price 05/23/2025 04:00 PM Eastern

Extended Trading

$6.35 -0.18 (-2.74%)

As of 05/23/2025 04:11 PM Eastern

Bioventus Inc., a medical device company, focuses on developing and commercializing treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical pain injection therapies, as well as peripheral nerve stimulation products, such as Durolane, GELSYN-3, and SUPARTZ for the treatment of knee osteoarthritis and Stimrouter to treat chronic peripheral pain. Its surgical solutions comprise bone graft substitutes that increase bone formation to stimulate bone healing in spinal fusions and other orthopedic surgeries; and ultrasonic products used for precise bone cutting and sculpting, soft tissue management, and tissue debridement, in various surgeries, including minimally invasive applications. The company's product include, Osteoamp, an allograft-derived bone graft for bone grafting procedures; Exponent matrix for posterolateral spine procedures; Purebone for bone grafting procedures; Signafuse bone graft; Interfuse bone graft; Osteomatrix+ synthetic bone graft; Extractor for autologous cell and bone marrow extraction; reficio bone matrix; nexus ultrasonic surgical system; bonescalpel surgical solution; SonaStar for surgical procedures; and SonicOne ultrasonic cleansing and debridement system. The company's restorative therapies include a bone stimulation system and devices to help patients regain leg or hand function due to stroke, multiple sclerosis, or other central nervous system disorders. Its products include exogen, a bone healing system; L300 GO, a foot drop system; H200 rehabilitation system; Vector, a body weight support system; and Bioness integrated therapy system. It developing Talisman pulse generator and receiver for peripheral nerve stimulation. The company was founded in 2011 and is headquartered in Durham, North Carolina.

OrthoPediatrics NASDAQ:KIDS

$20.83 -0.32 (-1.51%)

Closing price 05/23/2025 04:00 PM Eastern

Extended Trading

$20.83 0.00 (0.00%)

As of 05/23/2025 07:12 PM Eastern

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediguard, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIMTM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIROTM Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, and Mitchell Ponseti. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.

Profound Medical NASDAQ:PROF

$5.08 -0.04 (-0.88%)

As of 05/23/2025 04:00 PM Eastern

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum. The company also offers Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. Profound Medical Corp. is headquartered in Mississauga, Canada.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time